USPTO serial 77369148
LIPOBINDVITS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, JENNIFER MCGARRY
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LIPOBINDVITS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Croydon Surrey, GB
Croydon Surrey, GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Wheat for use as a dietary supplement; Meal replacement and dietary supplement drink mixes; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional oils not for food or cosmetic purposes; Nutritional supplements; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Powdered fruit-flavored dietary supplement drink mix; Powdered nutritional supplement drink mix; Processed food adapted for medical purposes; Protein reduced and gluten free food for medical purposes; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry; Vitamin and mineral supplements; Vitamin supplement in tablet form for use in making an effervescent beverage when added to water; Vitamin supplements; Dietary supplements; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietetic foods adapted for medical use; Fish, pickles, preserved olives and dietary foods and food-items that are gluten-free to accommodate special medical and health conditions; Food for babies; Food for diabetics; Food for enteral feeding; Food for infants; Food for medically restricted diets; Food supplements; Food supplements, namely, anti-oxidants; Freeze-dried food bait to attract flies for pest control purposes; Gluten-free food to accommodate special medical and health conditions; Ground flaxseed fiber for use as a dietary supplement; Herbal supplements; Homeopathic supplements; Lecithin for use as a dietary supplement; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Baby food; Baby foods; Bee pollen for use as a dietary food supplement; Biscuits, bread, bread rolls, cakes, cereal products, confectionery, crackers, noodles, fish sauce, relish, sauces, cereal-based snack-foods and prepared dietary items that are gluten-free to accommodate special medical and health conditions; Calcium supplements; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary fiber as an additive for food products; Dietary food supplements; Dietary supplemental drinks; Air fresheners and air freshening preparations; All purpose disinfecting and deodorizing preparations; Alloys of precious metal for use in dentistry and dentistry technology; Almond oil for pharmaceutical purposes; Almond oils for pharmaceutical purposes; Anesthetics for surgical and non-surgical use; Anti-arthritic compositions and preparations; Anti-diabetic pharmaceuticals; Anti-inflammatory and antipyretic preparations; Antibacterial pharmaceuticals; Antibacterial/antimicrobial tape for the purpose of destroying bacteria, mold and mildew; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Bacterial and bacteriological preparations for medical or veterinary purposes; Bacteriostats for medicinal, dental and veterinary use; Base metals and alloys for dentistry use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Bismuth preparations for pharmaceutical purposes; Bonding and primer materials for dental purposes; Cardiovascular pharmaceuticals; Carpet fresheners and odor eliminators; Cedar wood for use as a clothing protector and/or deodorizer; Composite materials for dental and dental technical purposes; Corn and callus creams; Dental resin for temporary bridges, crowns and veneers; Deodorizing products, namely, all purpose deodorizer preparations for household, commercial and industrial use; Dermatological pharmaceutical products; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents and contrast media for medical use; Dissolvable strips to stop bleeding from minor cuts and grazes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Embedding material for dental and dental technical purposes; Eye pillows containing aromatic substances for relief from headaches, insomnia and sinus discomfort; Fissure sealant for dental and dental technical purposes; Fluid for the topical fluoridation of tooth enamel and decay prevention; Fungicides and herbicides; Gases for medical and dental use; Gelatin capsules sold empty for pharmaceuticals; Germicides and fungicides; Greases and petroleum jelly for medical or veterinary purposes; Herbal anti-itch and sore skin ointment for pets; Herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; Herbicides, insecticides, pesticides and fungicides for home, garden and lawn use and for professional use; Human allograft bone and tissue; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Material for repairing teeth and for dental crowns and bridges; Material for tooth crowns and tooth bridges for dental and dental technical purposes; Materials for crowns and bridges for dental use and for oral prophylaxis; Materials for dental fillings and for sealing purposes; Medical and surgical dressings; Medical and surgical plasters; Medical cleansers for skin and wounds; Medical diagnostic reagents and assays for testing of body fluids; Medicated diaper rash ointments and lotions; Medicated mouth care and treatment preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicinal preparations for the mouth and as sprays; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 22, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 15, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 13, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| May 13, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 12, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 12, 2008 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 10, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 10, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 19, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 7, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 27, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2008 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| May 7, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 23, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 22, 2008 | ALIE | ASSIGNED TO LIE | — |
| Apr 17, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 16, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2008 | NWAP | NEW APPLICATION ENTERED | — |